Live From WCLC 2024: Sunday Highlights Podcast

Podcast | English | 2024 | 33 Min

Create Account

Cost

$0.00

Credit

No Credit Offered

In this special WCLC 2024 episode of Lung Cancer Considered, host Dr. Stephen Liu discusses daily highlights from the conference. Dr. Caicun Zhou discusses the results of ivonescimab versus embolisms in the first-line HARMONi-2 study. Dr. Tina Cascone discusses preliminary outcomes from the perioperative NeoCOAST-2 study, and Dr. Marina Chiara Garassino outlines the potential QCS-NMR TROP2 biomarker using data from TROPION-Lung01. Dr. Matthew Smeltzer shares the results of the 2024 IASLC Global Survey on Biomarker Testing and how they compare to findings from the previous survey in 2018.

Podcast Hosts:

Stephen Liu, MD, Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics, Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C., USA

Podcast Guests:

Tina Cascone, MD, Associate Professor, Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Marina Chiara Garassina, MD, Director, Thoracic Oncology Program and Professor of Medicine, University of Chicago, Chicago, IL, USA
Matthew Smeltzer, PhD, MStat, Associate Professor, Division of Epidemiology, Biostatistics and Environmental Health, University of Memphis, Memphis, TN, USA